A prominent neurologist at Billings’ St. Vincent Healthcare’s Multiple Sclerosis Center says a new MS treatment has doctors and patients cautiously optimistic that it can help people with a form of the disease that’s previously been considered untreatable.  Dr. Kris French is St. Vincent MS medical director and a neurologist who says there’s guarded hope at this stage of testing.  The treatment is called Ocrevus, and, if approved, would be the first treatment available to people with primary progressive MS.

But before that can happen, it needs approval by the U.S. Food and Drug Administration, a process that started earlier this year when the federal agency granted the drug an important priority review status and could see an approval decision handed down before the end of the 2016.  MS is a central nervous system disease that causes communication problems between the brain and the rest of the body.